The global prevalence of atopic dermatitis (a chronic skin disease) is expected to reach 42.42 million by 2033, according to a report released on Monday. The report by data and analytics company GlobalData showed that the global burden of prevalent cases of atopic dermatitis detected in 12 months is projected to increase at an annual growth rate (AGR) of 0.10 per cent from 42.02 million cases in 2023 to 42.42 million cases in 2033.

• These symptoms are seen-

The report says that this increase will be particularly evident in the US, France, Germany, Italy, Spain, the UK and Japan. The report shows that cases of atopic dermatitis, also known as eczema, are increasing due to the increasing prevalence of environmental and lifestyle risk factors and an increase in the incidence of atopic dermatitis in adulthood. Due to this, the patient experiences symptoms such as swelling, redness and intense itching.

“The exact cause of atopic dermatitis (ulcerative skin disease) is not clear, and it most likely results from a combination of genetic susceptibility, environmental and lifestyle factors,” said Yixuan Zhang, an epidemiologist at GlobalData.

According to GlobalData epidemiologists, in 2023, seven key markets accounted for approximately 44 percent of mild 12-month diagnosed prevalent cases of atopic dermatitis, 42 percent of moderate cases of atopic dermatitis, and 14 percent of severe cases of atopic dermatitis.

• Atopic dermatitis linked to sleep disturbances

Atopic dermatitis is a complex disease with many symptoms depending on the severity of the patient. In severe cases, atopic dermatitis is associated with sleep disturbances, itchy skin rashes that appear during depression, anxiety and depression. "Most cases appear in childhood, followed by middle-aged and older populations. A positive correlation has been found between a country's gross domestic product (GDP) and disease burden," Zhang said.

The prevalence of atopic dermatitis is increasing in low-income countries and new-onset atopic dermatitis is becoming increasingly common in adults.